Ataxia-Telangiectasia [Louis-Bar syndrome] Global Clinical Trials Review, Q1, 2011

GlobalData, February 2011, Pages: 30

Ataxia-Telangiectasia [Louis-Bar syndrome] Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, “Ataxia-Telangiectasia [Louis-Bar Syndrome] Global Clinical Trials Review, Q1, 2011" provides data on the Ataxia-Telangiectasia [Louis-Bar Syndrome] clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Ataxia-Telangiectasia [Louis-Bar Syndrome]. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables
List of Figures
Introduction
Ataxia-Telangiectasia [Louis-Bar syndrome]
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Sheba Medical Center
Clinical Trial Overview of Sheba Medical Center
Imperial College London
Clinical Trial Overview of Imperial College London
Institute of Child Health and Hospital for Children
Clinical Trial Overview of Institute of Child Health and Hospital for Children
National Eye Institute
Clinical Trial Overview of National Eye Institute
National Center for Research Resources
Clinical Trial Overview of National Center for Research Resources
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
University Hospital, Bonn
Clinical Trial Overview of University Hospital, Bonn
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Europe, Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, North America, Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Child Health and Hospital for Children, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bonn, 2011-

List of Figures
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Europe, Top Countries (%), 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Ataxia-Telangiectasia [Louis-Bar syndrome] Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011--
Methodology

Customers who bought this item also bought

• Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012
• Fragile X Syndrome Global Clinical Trials Review, H2, 2012
• Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012
• Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2012
• Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2013
• Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012
• Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011
• Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012
• Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2012
• Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2012